Product Code: ETC328468 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The human combination vaccines market in Indonesia is expected to register significant growth over the forecast period owing to an increase in awareness about health care among people, as well as government initiatives such as Universal Health Coverage (UHC) that aims at providing healthcare services for all citizens regardless of socio-economic condition or geographical region. Moreover, continuous efforts taken by institutions like WHO and UNICEF towards promoting immunization programs will drive further demand for these vaccines over coming years. Additionally , availability various government subsidies on vaccinations will lead to more affordability and accessibility making it possible for majority population access quality healthcare facilities resulting into higher demand for combination vaccines henceforth leading Indonesian human combination vaccine market grow with highest CAGR during the forecast period.
The Indonesia Human Combination Vaccines market is propelled by the government`s efforts to expand immunization coverage and address multiple diseases with a single vaccine dose. Combination vaccines offer convenience, reduce the number of healthcare visits, and enhance patient compliance. As public awareness about preventive healthcare grows, the demand for vaccines that provide protection against multiple diseases simultaneously increases. Government initiatives, partnerships with international organizations, and investments in healthcare infrastructure play a pivotal role in driving the adoption of human combination vaccines, ultimately contributing to improved public health outcomes.
Developing and introducing new combination vaccines can involve complex regulatory processes and safety considerations. Ensuring accessibility and affordability, along with building public awareness about the benefits of combination vaccines, might also be challenges.
The Indonesia Human Combination Vaccines market faced disruptions due to the COVID-19 pandemic`s focus on healthcare resources. Routine immunization programs encountered interruptions as resources were redirected to address the immediate crisis. This impacted the demand for non-COVID-19 vaccines, including human combination vaccines. However, as healthcare systems adapted to the "new normal," efforts to restore routine immunization and maintain vaccination schedules helped stabilize the market.
Key players could involve pharmaceutical companies engaged in vaccine development and manufacturing, such as PT. Bio Farma (Persero), which is a state-owned enterprise producing various vaccines including combination vaccines. International players like GlaxoSmithKline (GSK) and Sanofi Pasteur might also have a presence in this market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Human Combination Vaccines Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Human Combination Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Human Combination Vaccines Market - Industry Life Cycle |
3.4 Indonesia Human Combination Vaccines Market - Porter's Five Forces |
3.5 Indonesia Human Combination Vaccines Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Indonesia Human Combination Vaccines Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.7 Indonesia Human Combination Vaccines Market Revenues & Volume Share, By Combination Type, 2021 & 2031F |
3.8 Indonesia Human Combination Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Indonesia Human Combination Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in Indonesia |
4.2.2 Government initiatives to improve vaccination coverage |
4.2.3 Growing investments in healthcare infrastructure in Indonesia |
4.3 Market Restraints |
4.3.1 High cost associated with human combination vaccines |
4.3.2 Limited access to healthcare services in remote areas of Indonesia |
4.3.3 Regulatory hurdles and approval processes for new vaccines |
5 Indonesia Human Combination Vaccines Market Trends |
6 Indonesia Human Combination Vaccines Market, By Types |
6.1 Indonesia Human Combination Vaccines Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Human Combination Vaccines Market Revenues & Volume, By Product Type, 2021-2031F |
6.1.3 Indonesia Human Combination Vaccines Market Revenues & Volume, By Inactivated Vaccine, 2021-2031F |
6.1.4 Indonesia Human Combination Vaccines Market Revenues & Volume, By Live Attenuated Vaccine, 2021-2031F |
6.2 Indonesia Human Combination Vaccines Market, By Age Group |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Human Combination Vaccines Market Revenues & Volume, By Children, 2021-2031F |
6.2.3 Indonesia Human Combination Vaccines Market Revenues & Volume, By Adults, 2021-2031F |
6.3 Indonesia Human Combination Vaccines Market, By Combination Type |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Human Combination Vaccines Market Revenues & Volume, By Dtap/IPV/HEP B, 2021-2031F |
6.3.3 Indonesia Human Combination Vaccines Market Revenues & Volume, By Dtap/HIB/IPV, 2021-2031F |
6.3.4 Indonesia Human Combination Vaccines Market Revenues & Volume, By MMR II, 2021-2031F |
6.3.5 Indonesia Human Combination Vaccines Market Revenues & Volume, By HEP B-HIB, 2021-2031F |
6.3.6 Indonesia Human Combination Vaccines Market Revenues & Volume, By Others, 2021-2031F |
6.4 Indonesia Human Combination Vaccines Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Indonesia Human Combination Vaccines Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.4.3 Indonesia Human Combination Vaccines Market Revenues & Volume, By Retailer Pharmacies, 2021-2031F |
6.4.4 Indonesia Human Combination Vaccines Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Indonesia Human Combination Vaccines Market Import-Export Trade Statistics |
7.1 Indonesia Human Combination Vaccines Market Export to Major Countries |
7.2 Indonesia Human Combination Vaccines Market Imports from Major Countries |
8 Indonesia Human Combination Vaccines Market Key Performance Indicators |
8.1 Immunization coverage rates in key target populations |
8.2 Number of public-private partnerships in the vaccination sector |
8.3 Research and development spending on new vaccine technologies and formulations |
8.4 Number of vaccine preventable diseases outbreaks in Indonesia |
8.5 Adoption rate of new vaccination guidelines by healthcare providers |
9 Indonesia Human Combination Vaccines Market - Opportunity Assessment |
9.1 Indonesia Human Combination Vaccines Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Indonesia Human Combination Vaccines Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.3 Indonesia Human Combination Vaccines Market Opportunity Assessment, By Combination Type, 2021 & 2031F |
9.4 Indonesia Human Combination Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Indonesia Human Combination Vaccines Market - Competitive Landscape |
10.1 Indonesia Human Combination Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Human Combination Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |